← Back
Principles of Diagnostic Medicine I Exam 2 · Class of 2028

Principles of Diagnostic Medicine I Exam 2 Cram Sheet

Lectures 7, 8, 9 and 10. Electrocardiography — the action potential, the conduction system, paper, leads, rate and the normal intervals. Cardiac imaging — the chest radiograph, echocardiography, stress testing, nuclear, computed tomography, magnetic resonance, angiography and vascular ultrasound. Cardiac biomarkers and lipid testing. Coagulation and hemostasis testing — the three phases, the platelet, PT, INR, aPTT, thrombin time, fibrinogen and D-dimer tests, and how to read the patterns. Opens with how the exam is written.

How to use this: this is a condensed, night-before-the-exam reference, not a replacement for the full study guide — it assumes you've already learned the material and just need the highest-yield facts at a glance. If a term feels unfamiliar, go back to the full guide for the explanation.

How This Exam Is Written

TermWhat you need to know
Reference ranges are GIVEN“I'm not going to just throw a random number at you” — a troponin, triglyceride or C-reactive protein in a stem comes with the limit that reads it. Learn what a value MEANS.
Name the rhythmElectrocardiography is the one place where naming the finding is fair game. Lecture 7 is the toolkit: paper, leads, rate, intervals.
Next-best-test“What would be the next test that you would order?” Know what each imaging study can and cannot show, and what to do when one is equivocal.
★ Two calculations ARE examinableFriedewald LDL-C and non-HDL-C, worked in class on the Lecture 9 practice slide: “two calculations, and then we have to interpret.” The newer LDL equations are calculator-only.
Not examined (said out loud)Ion-channel subtypes (but which ion moves in each phase IS). Bazett's formula (“I will never ask you about the formula”). The bifascicular-block aside. The order of the exercise-endpoint chart and the treadmill protocol tables.

Action Potential & Refractory Periods

TermWhat you need to know
Four cell propertiesAUTOMATICITY (makes its own impulse) · EXCITABILITY (responds to one) · CONTRACTILITY · CONDUCTIVITY (passes it on).
Phase order4 → 0 → 1 → 2 → 3. “You need to know what happens in each phase.”
Phase 4 / 04 = rest (diastole), −90 mV, potassium inside. 0 = upstroke: FAST SODIUM CHANNELS open, sodium rushes in.
Phase 1 / 2 / 31 = early repolarization (sodium closes). 2 = PLATEAU: CALCIUM IN causes contraction, balanced by potassium OUT. 3 = rapid repolarization: calcium closes, potassium out, back to −90 mV. (Slide text says potassium “in”; its own figure shows efflux.)
Depolarization vs repolarizationDepolarization = membrane LESS negative, ACTIVATION, PRECEDES contraction. Repolarization = return toward rest, RECOVERY.
Absolute refractoryWill NOT respond. Phase 0 to MID phase 3, about 180 ms.
Relative refractoryWILL respond but fragile. Mid phase 3 to END of phase 3. The T-WAVE PEAK divides the two. Basis of R on T, P on T and the danger of a long QTc.

Conduction System

TermWhat you need to know
Sinoatrial nodeMain pacemaker, upper right atrium below the vena cava. 60–100 per minute. Three internodal tracts; most people use the superior anterior (FAST) tract.
Atrioventricular nodeNear the coronary sinus. PAUSES and AMPLIFIES the signal; back-up pacemaker. 40–60 per minute.
Bundle of HisThe ONLY electrical path from atria to ventricles in a normal heart, through the nonconductive atrioventricular septum.
Bundle branchesLeft splits into THREE fascicles (posterior, septal, anterior). Right is MUCH LONGER than the left. Bifascicular block is NOT a left bundle branch block.
Purkinje networkThird pacemaker, 20–40 per minute; fastest conduction of all.
Cardiac vectorDirection and strength of current; true pathway is LEFT AND DOWN toward the anterior chest.

Paper, Leads & Rate

TermWhat you need to know
TimeSmall box 0.04 s · large box 0.2 s · 5 large boxes = 1 s. Strips are 3 or 6 seconds.
VoltageSmall box 1 mm = 0.1 mV; 10 mm (two large boxes) = 1 mV.
Bipolar vs unipolarBIPOLAR = two electrodes: I, II, III (Einthoven's triangle). UNIPOLAR = one electrode: aVR, aVL, aVF (augmented) and V1–V6.
10 wires, 12 leadsFour limb electrodes make SIX hexaxial leads (I, II, III, aVR, aVL, aVF, used for axis); plus six chest leads. Placement must be MEMORIZED.
Lead IIBest view of the heart's vector, so it is the RHYTHM lead.
Which leads look whereInferior II, III, aVF · septum V1–V2 · anterior V3–V4 · lateral I, aVL, V5–V6. Anteroseptal infarction shows in V1–V4 (both supplied by the left anterior descending artery).
Cannot tell youHemodynamic status, cardiac output, or WHETHER THERE IS A PULSE.
Rate methodsREGULAR rhythms only. 6-second: QRS count × 10 (P count × 10 for atrial). 300 method: heavy lines count 300, 150, 100, 75, 60, 50.

Waves & Intervals

TermWhat you need to know
P waveAtrial depolarization; under 0.12 s; upright in lead II.
PR interval0.12–0.20 s (3–5 small boxes): atria, atrioventricular node delay, His-Purkinje.
QRSVentricular depolarization; under 0.12 s, narrow and sharp. Q = septum, R = anterior left ventricle, S = lateral left ventricle.
J point & STJ point = end of QRS, start of ST; at baseline (1 mm variance). “Very important that you know how to identify the J point.” ST = ventricles holding contraction; at baseline.
T waveVentricular repolarization, 0.16–0.25 s.
QT / QTcStart of QRS to end of T. 350–450 ms males, 360–460 ms females. QTc = rate-corrected; above 450 (460) to 500 = borderline; ABOVE 500 ms = HIGH-RISK.
U wave & TPU: after T, same direction, best V2–V3; prominent in hypokalemia, hypercalcemia, long QT, post-infarction. TP segment = best place to judge the isoelectric line.
The systemRhythm → rate → P waves → P for every QRS → QRS width → PR → ST → T → QTc → extra waves or beats → voltage.

Chest Radiograph & Cardiothoracic Ratio

TermWhat you need to know
Its standingNOT the primary modality for function or detailed anatomy, but gives clues when obtained: silhouette, great vessels, pulmonary vasculature, lungs and pleura.
Right borderSuperior vena cava → right atrium.
Left borderAortic knuckle → main pulmonary artery → left atrial appendage → left ventricle (forms the apex).
Cardiac findingsPulmonary edema · pleural effusion · cardiomegaly · CEPHALIZATION · great vessel, valve or pericardial calcification · tension physiology.
CephalizationUpper-lobe vessels bigger than lower. Heart failure or pulmonary hypertension.
Cardiothoracic ratioWidest heart ÷ widest INTERNAL thorax. Normal 0.42–0.5; ABOVE 0.5 on a PROPER POSTEROANTERIOR film suggests cardiomegaly.

Echocardiography & Stress Testing

TermWhat you need to know
Echo showsSTRUCTURE AND FUNCTION: chambers, walls, ejection fraction, Doppler flow, valves, shunts, pressures.
TTE (transthoracic echocardiogram)Most common, bedside, noninvasive. Poor for the POSTERIOR heart.
TEE (transesophageal echocardiogram)Probe in the esophagus. Aorta and great vessels, myxoma, prosthetic valves, VEGETATIONS, cerebral ischemia, LEFT ATRIAL APPENDAGE THROMBUS.
TEE contraindicationsAnything the probe can injure or an airway you cannot protect: esophageal stricture, malignancy, bleeding varices; dysphagia; ZENKER'S DIVERTICULUM; cervical arthritis; sleep apnea; uncooperative patient.
Valid exercise testAt least 85% of predicted maximum; predicted maximum = 220 − AGE. Under 85% cannot exclude ischemia.
Exercise test readsIschemia indirectly: ST DEPRESSION or new premature ventricular contractions. Bruce protocol; bicycle preferred.
Echo stressCan exercise but baseline ST-T changes. Look for NEW WALL-MOTION abnormality right after exercise.
Pharmacologic stressCannot exercise. ADENOSINE or DIPYRIDAMOLE vasodilate; DOBUTAMINE raises workload.

Nuclear, CT (Computed Tomography) & MRI (Magnetic Resonance Imaging)

TermWhat you need to know
Nuclear perfusionTracer at rest and after stress. Less uptake after stress = ischemia; NO uptake = dead tissue (VIABILITY). More accurate than standard or echo stress.
Coronary CT angiographyPresence and distribution of coronary disease; detect or exclude stenosis or plaque; EQUIVOCAL OR NON-DIAGNOSTIC STRESS TEST → next best step.
Cardiac CTNon-contrast = CALCIUM SCORING. Metoprolol slows the heart, nitroglycerin dilates, electrocardiogram gating.
CT limitsANATOMY ONLY, NOT FUNCTION. Radiation, contrast, rate dependent, BLOOMING artifact overstates calcium.
Cardiac magnetic resonanceAnatomy, function, viability, perfusion, INFLAMMATION — no ionizing radiation or iodinated contrast. ECHO FIRST. Aorta, congenital disease, cardiomyopathies, myocarditis, sarcoid.
Magnetic resonance limitsImplants (aneurysm clips, some pacemakers), long acquisition, claustrophobia. Titanium is acceptable.

Angiography, Catheterization & Vascular Ultrasound

TermWhat you need to know
GOLD STANDARDCoronary angiography for coronary disease — “a high-miss last year.” Can treat in the same sitting (balloon, stent).
Why go to the catheterNoninvasive tests say IF disease is there; angiography says HOW MUCH, and intervention is by percentage. Positive CT angiogram with left anterior descending disease → catheter.
Left vs right heart cathLEFT (artery) = CORONARY ARTERIES. RIGHT (vein) = PULMONARY HYPERTENSION.
ComplicationsAccess-site HEMATOMA and PSEUDOANEURYSM (pulsatile, communicates with the artery). Always check the site.
Electrophysiology testingCatheters via a vein into the right heart provoke and locate an arrhythmia; ablation can treat it.
Vascular ultrasoundVeins COLLAPSE, arteries PULSATE on compression. Deep vein thrombosis, carotid, peripheral arterial disease, aneurysm, venous insufficiency. No radiation; HIGHLY OPERATOR DEPENDENT.

The Four Cardiac Biomarkers

TermWhat you need to know
★ One word eachCRP = INFLAMMATION · BNP = STRETCH, so volume · troponin = INJURY (“troponin is your friend”). “If you have troponin, don't even waste your time ordering a CK.”
The frameBiomarkers: “is there ACUTE cardiac injury or stress?” Lipids: “what is the LONG-TERM atherosclerotic risk?”
TroponinMyocyte INJURY. Marker of choice. Infarction = above the 99th PERCENTILE upper reference limit + ischemic symptoms. Sex-specific limits.
Troponin subunitsI = CARDIAC SPECIFIC. T = mostly cardiac, trace skeletal. C = NOT useful.
High-sensitivity troponinThe ASSAY, not a subunit. Draw at 0 and 1–2 HOURS; up to 90 minutes earlier. Pitfall: measurable in healthy people.
Injury vs infarctionInjury = any elevation. Infarction = injury + ISCHEMIA + RISING/FALLING pattern. Chronically raised in kidney disease, heart failure, structural disease — never read one value alone.
Creatine kinaseSkeletal muscle: RHABDOMYOLYSIS, STATIN MYOPATHY. Low cardiac specificity. Creatine kinase-MB, myoglobin, lactate dehydrogenase are RETIRED for infarction.
BNP (B-type natriuretic peptide)STRETCH, not injury. Rule-out of new heart failure; monitor, guide, prognosis. Rises with age, female sex, kidney disease; FALSELY LOW IN OBESITY. Not stand-alone.
hs-CRP (high-sensitivity C-reactive protein)Inflammation; a RISK ENHANCER, never an acute test. Non-specific. Highest in bacterial infection. Lowered by statins, NSAIDs (nonsteroidal anti-inflammatory drugs), GLP-1 (glucagon-like peptide-1) agonists, lifestyle. In the Reynolds Risk Score.

When to Order Which

TermWhat you need to know
★ Acute chest pain, in fullTroponin + EKG as soon as possible, plus a metabolic panel for KIDNEY FUNCTION (to read the troponin, for cath-lab contrast, for diabetes and hypertension). hs-CRP is “an office visit type lab”, never the chest-pain answer.
Chest painSERIAL HIGH-SENSITIVITY TROPONIN, first-line; first value is also prognostic.
Dyspnea / heart failureBNP (B-type natriuretic peptide) or NT-proBNP (N-terminal pro B-type natriuretic peptide); also prognostic after acute coronary syndrome.
Muscle pain on a statinCREATINE KINASE, not troponin.
Risk refinemenths-CRP (high-sensitivity C-reactive protein) in select primary prevention.
Do NOT orderRoutine natriuretic peptides in healthy people; creatine kinase-MB or myoglobin for infarction.
Troponin, other usesUnstable angina (normal = no injury) · reinfarction · infarct size (late 4-week value INVERSELY related to ejection fraction) · procedural: type 4a more than 5×, type 5 (bypass) more than 10× the 99th percentile limit.

Lipoproteins & Apolipoproteins

TermWhat you need to know
Why particlesCholesterol and triglycerides are INSOLUBLE. Lipoprotein = lipid core + phospholipid shell + apolipoproteins.
One apoB particleLiver VLDL (very low-density lipoprotein) → lipoprotein lipase strips triglyceride → remnant → LDL (low-density lipoprotein). Under ~70 nm can be TRAPPED in the artery wall.
ApoB-48 / ApoB-100B-48 = intestine, CHYLOMICRONS. B-100 = liver: very low-, intermediate-, low-density lipoprotein and lipoprotein(a). NOT in HDL (high-density lipoprotein).
ApoA-I / ApoEA-I = ALL HDL (high-density lipoprotein). E = triglyceride CLEARANCE. C-III and A-V regulate triglyceride metabolism.
LDL vs HDLLDL (low-density lipoprotein) = PRINCIPAL DRIVER, log-linear with risk. HDL = REVERSE CHOLESTEROL TRANSPORT. Remnants carry RESIDUAL risk.
Lipoprotein(a)LDL-like + apo(a) on apoB-100. Over 90% GENETIC, stable, NO FASTING, measure ONCE in all adults; repeat after menopause if borderline; CASCADE test families. STATINS DO NOT LOWER IT. About 20% of people elevated.

Ordering & Reading a Lipid Panel

TermWhat you need to know
★ LDL-C goal, both endsNo single normal, so know the ends: average risk UNDER 100 · highest risk UNDER 55 (middle tier under 70). “LDL is the big one.” Golf, not bowling.
★ Well patient + family historySCREENING, not diagnostic (the slide's asterisk): fasting lipid panel, A1C, lipoprotein(a) if never measured.
MeasuredTotal cholesterol, HDL-C (high-density lipoprotein cholesterol), triglycerides.
CalculatedLDL-C (low-density lipoprotein cholesterol) — an ESTIMATE — and non-HDL-C = total cholesterol − HDL-C.
FriedewaldLDL-C = total − HDL-C − triglycerides ÷ 5. INVALID when triglycerides are 400 mg/dL or above; Martin/Hopkins or Sampson/NIH (National Institutes of Health) preferred.
Non-HDL-CEvery atherogenic apoB lipoprotein, NO added cost, BETTER predictor than LDL-C.
No single normalLDL-C and non-HDL-C goals depend on RISK TIER; triglyceride, apoB and lipoprotein(a) thresholds are fixed. HDL-C is a MARKER, not a target.
Triglycerides150+ = risk enhancer · 500+ = SEVERE, PANCREATITIS risk · 1000+ = extreme.
ApoBModifiable, repeated to monitor therapy; use with triglycerides 150+, diabetes or low LDL-C to find residual risk.
Fasting?NONFASTING for most. Fasting with triglycerides 400+, a triglyceride disorder, or FAMILY HISTORY OF PREMATURE DISEASE or genetic dyslipidemia.
ScreeningChildren 9–11 (from age 2 with family history or familial hypercholesterolemia) · again at 19 · adults about EVERY 5 YEARS · on therapy recheck 4–12 WEEKS, then every 6–12 months.

Risk Assessment

TermWhat you need to know
PREVENT (Predicting Risk of cardiovascular disease EVENTs)Lipids feed a 10-YEAR risk estimate, which sets treatment intensity.
Calculate → Personalize → ReclassifyLow under 3% · borderline 3 to under 5% (add RISK ENHANCERS) · intermediate 5 to under 10% · high 10% or above.
Uncertain?At borderline or intermediate risk, a CORONARY ARTERY CALCIUM SCORE reclassifies.
LDL-C goalsUnder 100 if risk under 10% · under 70 if 10%+, familial hypercholesterolemia, diabetes with risk factors, or calcium 100+ · under 55 for very-high-risk clinical disease. 190+ = statin regardless of risk.
Elevated lipoprotein(a)Earlier, more intensive control of EVERY OTHER risk factor.

Hemostasis: The Terms & Three Phases

TermWhat you need to know
★ The frame (three phases)Hemostasis = the BALANCE between clot formation and clot breakdown. EACH TEST evaluates ONE PART of that balance.
HemostasisArrest of bleeding from an injured vessel, while preventing pathologic thrombosis.
Primary hemostasisFormation of a PLATELET PLUG at the site of injury. von Willebrand factor tethers platelets to collagen; they aggregate through glycoprotein IIb/IIIa.
Secondary hemostasisInsoluble, cross-linked FIBRIN from activated coagulation factors, specifically THROMBIN (the cascade).
ThrombusA clot formed IN SITU within the vascular system that impedes flow.
FibrinolysisEnzymatic breakdown of fibrin: tissue plasminogen activator makes PLASMIN, which degrades fibrin.
Fibrin degradation productsFragments after PLASMIN degrades fibrinogen or fibrin; markedly raised in disseminated intravascular coagulation.
D-dimerA cross-linked fibrin degradation product from THREE enzymes: thrombin, activated factor XIII, plasmin.
Pathway mapExtrinsic = tissue factor + factor VII. Intrinsic = XII, XI, IX, VIII. Both feed factor X; common = X, V, II, I, XIII. Thrombin activates VIII, V and XIII. Vitamin K deficiency hits II, VII, IX, X.

Primary Hemostasis Tests (Platelets)

TermWhat you need to know
Platelet countAdults 140,000–400,000 per microliter. The deck calls thrombocytopenia below 100,000 and thrombocytosis above 350,000.
Mean platelet volumeUNIFORMITY OF PLATELET SIZE; used in the differential diagnosis of thrombocytopenia. Normal 7.4–10.4 femtoliters.
SmearPlatelet MORPHOLOGY: macrothrombocytopenia, gray platelets, neutrophil inclusions, clumps.
★ von Willebrand studiesvon Willebrand factor ANTIGEN and ACTIVITY plus a factor VIII level. von Willebrand disease = MOST COMMON inherited bleeding disorder.
Platelet function testsLight transmission aggregometry, lumiaggregometry, platelet function analyzer (PFA-100), flow cytometry.
Bleeding timeMinutes for a standard skin puncture to stop bleeding (3–10). ONLY USEFUL if the platelet count is ABOVE 100,000, because thrombocytopenia itself lengthens it. Largely replaced in practice.
False low countLow count? CONFIRM in a citrated or heparinized tube: EDTA (ethylenediaminetetraacetic acid) can make platelets CLUMP (pseudothrombocytopenia). The smear shows clumps and satellitism.

Secondary Hemostasis Tests

TermWhat you need to know
PT (prothrombin time)Clot time after TISSUE FACTOR is added: EXTRINSIC + common. Liver-made, VITAMIN K dependent. Reference 11–13 seconds. Prolonged: factor VII, liver disease, vitamin K deficiency, warfarin.
★ INR (international normalized ratio)PT STANDARDIZED across laboratories. Reference 0.8–1.2; on anticoagulation the goal is typically 2.0–3.0. On warfarin LOW = CLOT risk, HIGH = BLEEDING risk.
aPTT (activated partial thromboplastin time)Clot time after a PHOSPHOLIPID ACTIVATOR: INTRINSIC + common. Reference 21–35 seconds; above 70 seconds signifies spontaneous bleeding. Prolonged: VIII, IX, XI, heparin, inhibitor, lupus anticoagulant, XII.
Thrombin timeRaised by HEPARIN and DABIGATRAN; normal in a simple factor deficiency.
FibrinogenCLAUSS assay preferred. Reference 2.0–4.0 g/L. LOW = BLEED (below 0.5 g/L: hemorrhage after traumatic surgery). HIGH = CLOT (above 7.0 g/L: coronary and cerebrovascular risk). Raised in tissue damage or inflammation.
Mixing studyMix with normal plasma. CORRECTS = factor DEFICIENCY. Does NOT correct = INHIBITOR.
Factor assaysCONFIRM a deficiency; inherited or acquired; acquired can raise or lower levels.
CaveatsNormal PT/INR does NOT rule out coagulopathy. Low-molecular-weight heparin and most direct oral anticoagulants may not derange PT/aPTT yet raise bleeding risk; no routine monitoring. PREGNANCY: PT, aPTT, thrombin time shorten; fibrinogen and D-dimer RISE. Mild PT/aPTT prolongation does not predict bleeding.

D-dimer & Fibrinolysis Tests

TermWhat you need to know
D-dimerNormal below 250 micrograms per liter. Produced ONLY by plasmin on cross-linked fibrin: confirms BOTH thrombin and plasmin were generated. NONSPECIFIC.
★ D-dimer: best useHigh NEGATIVE predictive value: a NORMAL result helps EXCLUDE thrombosis. Raised in acute thrombosis, DIC (disseminated intravascular coagulation), pregnancy and many acute illnesses.
Fibrin monomersPOSITIVE = thrombin activity, consistent with intravascular coagulation. NEGATIVE does NOT exclude it. Also positive in some severe liver disease and inflammatory disorders.
Clot vs breakdownThrombin = clot generation; plasmin = clot breakdown.
Other fibrinolysis testsEuglobulin clot lysis time; alpha-2 antiplasmin and plasminogen activator inhibitor 1 assays.

Memory Aid: The Wall-Building Crew

TermWhat you need to know
A story, not a factThe lecturer's own picture: platelets are the BRICKS, clotting factors the MORTAR. A vessel is a flood wall; bleeding is a breach; hemostasis is a repair crew against a demolition crew. Full story in guide 10.0, with where it breaks.
Bricks (primary hemostasis)Platelets = bricks. von Willebrand factor = scaffolding hooks that bolt bricks to the bare wall. Glycoprotein IIb/IIIa and fibrinogen = clips between bricks. Prostacyclin = non-stick coating on healthy wall. Too few bricks = bleeding tiers.
Mortar crew (secondary hemostasis)Factors make the mortar: the workers that mix it (prothrombin comes from the liver); vitamin K licenses II, VII, IX, X (warfarin revokes it). Tissue factor + VII = outside alarm (PT). XII, XI, IX, VIII = inside chain (aPTT). X with V = shared foreman. Thrombin = master mixer; fibrinogen = powder; fibrin = wet mortar; XIII = hardener.
Brakes and saboteursAntithrombin III, protein C, protein S = safety inspectors (deficient = clots; low in DIC). Heparin and dabigatran = saboteurs at the mixers (aPTT and thrombin time up). Mixing study: spare crew corrects = a worker is missing; no correction = a saboteur.
Demolition crew (fibrinolysis)Plasminogen waits, tissue plasminogen activator calls it out, plasmin tears down hardened mortar. FIBRIN DEGRADATION PRODUCTS = rubble. D-DIMER = rubble from HARDENED mortar only (thrombin + XIII + plasmin): it proves a wall was built and torn down, never WHICH wall, so a normal one helps exclude thrombosis.
Disseminated intravascular coagulationBoth crews run wild everywhere: bricks used up (platelets down), powder used up (fibrinogen down), mortar slow (PT and aPTT up), rubble everywhere (D-dimer up). Nothing is normal.

Reading the Patterns

TermWhat you need to know
Start hereBleeding workup: blood count with smear, PT/INR, aPTT, fibrinogen. INTERPRET BY THE PT/aPTT PATTERN FIRST.
★ Where to beginAn abnormal PTT means CLOTTING FACTORS (secondary hemostasis), never platelets. Normal PT and aPTT with bleeding means think PLATELETS (function, von Willebrand). Bleeding and clotting use the SAME tests; the INR places a patient on the clot-to-bleed spectrum.
PT up, aPTT normalFactor VII, early vitamin K deficiency, liver disease, warfarin (or oral factor Xa inhibitor).
PT normal, aPTT upIntrinsic: VIII, IX, XI; von Willebrand disease; heparin or dabigatran (thrombin time up too); inhibitor; LUPUS ANTICOAGULANT or FACTOR XII (no bleeding history).
PT up AND aPTT upCommon pathway or combined deficiency, DIC, liver disease, severe vitamin K deficiency. Normal thrombin time = X, V, II; prolonged = fibrinogen problem.
★ Normal PT AND aPTT, yet bleedingPlatelet disorder, mild von Willebrand disease, factor XIII or alpha-2 antiplasmin deficiency, impaired fibrinolysis.
★ DIC patternPT up, aPTT up, fibrinogen DOWN, D-dimer UP, platelets DOWN. Protease inhibitors (protein C, antithrombin, protein S) DOWN. Every abnormality has other causes; the PATTERN matters.
Acute thrombosis patternONLY the D-dimer is up (nonspecific); PT, aPTT, fibrinogen, platelets normal.
Factor XIIProlongs the aPTT but does NOT cause bleeding.
★ Isolated long aPTTRule out HEPARIN first, then fibrinogen. Corrects on mixing = factor deficiency: low VIII, then von Willebrand studies (abnormal = von Willebrand disease, normal = HEMOPHILIA). Does not correct = inhibitor: phospholipid-dependent = LUPUS ANTICOAGULANT (dilute Russell viper venom time).
Reptilase timeNormal with heparin; assesses FIBRINOGEN function.

Platelet Abnormalities

TermWhat you need to know
★ Bleeding tiersBelow 50,000: bruises easily, bleeds with trauma or mucosal surgery. Below 20,000: SPONTANEOUS bleeding, PETECHIAE. Below 10,000: spontaneous INTRACRANIAL bleeding.
QuantitativeThrombocytopenia AND extreme thrombocythemia (above 1,000 × 10⁹ per liter) can BOTH bleed.
MorphologyGray platelets = gray platelet syndrome; neutrophil inclusions = May-Hegglin; clumps = spurious low count; fragmented red cells (schistocytes) = thrombotic thrombocytopenic purpura.
★ QualitativeNormal PT and aPTT WITH bleeding = platelet dysfunction: von Willebrand types 2 and 3, uremia, drugs (aspirin).
Low count, normal clotting timesImmune thrombocytopenia, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, heparin-induced thrombocytopenia (normal PT, aPTT, platelet function analysis).
Platelet function analysis abnormalvon Willebrand disease, DIC, uremia, aspirin and other nonsteroidal anti-inflammatory drugs, late liver failure. NORMAL in hemophilia A or B.
Low count: causesImpaired production · increased destruction (immune, microangiopathy, CONSUMPTION in DIC) · dilution (massive transfusion) · SEQUESTRATION (hypersplenism).

Indications & the Two Workups

TermWhat you need to know
IndicationsSymptomatic bleeding; preprocedural risk (but mild prolongation does not predict bleeding); WARFARIN monitoring; DIC, liver disease, vitamin K deficiency; suspected thrombosis (D-dimer to rule OUT).
Five screening testsPlatelet count/size/shape, bleeding time, aPTT, PT, fibrinogen. Then factor assays and fibrinolysis tests.
Bleeding workupBlood count with smear, PT/INR, aPTT, fibrinogen: the FACTOR AND PLATELET screens.
Thrombotic workupPT, aPTT, D-DIMER (thrombin-generation markers); most abnormal in DIC. PT and D-dimer are independent risk factors for arterial thrombosis.
Hypercoagulable testingPrimary causes: antithrombin III, protein C, protein S (the slide also lists factor XII, which is not an established thrombophilia); fibrinolytic mechanisms. Tests: anticoagulant factors (incl. LUPUS ANTICOAGULANT), fibrinogen, PT, aPTT, thrombin time.
Inherited bleeding, screens normalSkin bruising, petechiae, mucosal = platelet disorder or mild vWD · hemarthroses/deep hematoma = fibrinolytic inhibitor deficiency (euglobulin clot lysis time) · umbilical stump bleeding = FACTOR XIII.
Inherited bleeding, screens prolongedPT only = VII. aPTT only = VIII (hemophilia A), IX (hemophilia B), XI, severe von Willebrand disease. Both = X, V, II (normal thrombin time) or fibrinogen (prolonged thrombin time). Bleeding into joints and muscles = factor deficiency.